Stocks Comparison
ELI LILLY vs Pfizer: revenue, profit, margins and growth compared
ELI LILLY brought in $65.2B of revenue in fiscal 2025, Pfizer $62.6B in fiscal 2025. Revenue changed by +44.7% at ELI LILLY and -1.6% at Pfizer on the year before, so ELI LILLY grew faster. ELI LILLY kept 31.7% of its revenue as net profit, Pfizer 12.4%.
Side by side, latest fiscal year
| LLY | PFE | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $65.2B | $62.6B |
| Revenue growth | +44.7% | -1.6% |
| Net income | $20.6B | $7.8B |
| Net margin | 31.7% | 12.4% |
| Free cash flow | n/a | $9.1B |
| Free cash flow margin | n/a | 14.5% |
| Earnings per share (diluted) | $22.95 | $1.36 |
| Cash | $7.3B | $1.1B |
| Debt | $40.9B | $64.6B |
| Price to earnings | 51.6 | 21.1 |
| Market value | $1.11T | $163.4B |
| Dividend yield | 0.53% | 6.00% |
| Rank by revenue in sector | #11 of 523 · Health care | #13 of 523 · Health care |
Over the years
Questions about ELI LILLY and Pfizer
Which is bigger by revenue, ELI LILLY or Pfizer?
ELI LILLY is bigger by revenue: $65.2B in fiscal 2025, against $62.6B for Pfizer in fiscal 2025.
Which keeps more of its revenue as profit, ELI LILLY or Pfizer?
ELI LILLY had a net margin of 31.7% in fiscal 2025; Pfizer had 12.4% in fiscal 2025.
Which grew revenue faster, ELI LILLY or Pfizer?
In their latest fiscal years revenue changed by +44.7% at ELI LILLY and -1.6% at Pfizer.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.